Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in osteoblasts

Endocrinology

Volumn 141, Issue 12, 2000, Pages 4711-4719

  Takami, Masamichi ^a   Takahashi, Naoyuki ^a   Udagawa, Nobuyuki ^a   Miyaura, Chisato ^c   Suda, Koji ^b   Woo, Je Tae ^b   Martin, T John ^d   Nagai, Kazuo ^b   Suda, Tatsuo ^a  

^a SHOWA UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^d ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALPHOSTIN; CYCLIC AMP; FORSKOLIN; GLYCOPROTEIN GP 130; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IONOMYCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; STAUROSPORINE; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CULTURE MEDIUM; GENE EXPRESSION REGULATION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL;

EID: 0034522704     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.12.7852     Document Type: Article

References (38)

1. Evidence for the induction of two antibodies with identical combining sites in outbred animals
2. Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue
3. Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants
4. Modulation of osteoclast differentiation: Update 1995
5. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
6. Conditionally immortalized murine bone marrow stromal cells mediate parathyroid hormone-dependent osteoclastogenesis in vitro
7. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene
8. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: Studies using VDR knockout mice
9. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
10. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
11. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
12. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
13. A new member of tumor necrosis factor ligand family ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function
14. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
15. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
16. RANK is essential for osteoclast and lymph node development
17. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
18. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
19. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
20. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
21. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
22. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation
23. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs
24. 3 or parathyroid hormone
25. 2+-ionophore induce osteoclast-like cell formation in the cocultures of mouse bone marrow cells and calvarial cells
26. Divalent cation ionophores stimulate resorption and inhibit DNA synthesis in cultured fetal rat bone
27. 3 in osteoclast differentiation and function
28. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures
29. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
30. Structural and functional diversities of a family of signal transducing protein kinases, protein kinase C family; two distinct classes of PKC, conventional cPKC and novel nPKC
31. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
32. Parathyroid hormone causes translocation of protein kinase-C from cytosol to membranes in rat osteosarcoma cells
33. Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation to the same extent as PTH in mouse marrow cultures
34. Modulation of osteoclast differentiation
35. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells
36. The relationship of monocytic cells to the differentiation and resorption of bone
37. Bone: Formation by autoinduction
38. Bone modelling in the implantation bed